These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36006428)

  • 121. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
    Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
    Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
    Agüloğlu N; Aksu A; Unat DS
    Nucl Med Commun; 2023 Apr; 44(4):302-308. PubMed ID: 36756766
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of
    Isik EG; Kuyumcu S; Kebudi R; Sanli Y; Karakas Z; Cakir FB; Unal SN
    Ann Nucl Med; 2017 Nov; 31(9):660-668. PubMed ID: 28741053
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Role of radiomic analysis of [
    Marturano F; Guglielmo P; Bettinelli A; Zattoni F; Novara G; Zorz A; Sepulcri M; Gregianin M; Paiusco M; Evangelista L
    Eur Radiol; 2023 Oct; 33(10):7199-7208. PubMed ID: 37079030
    [TBL] [Abstract][Full Text] [Related]  

  • 125. A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer.
    Lim CH; Koh YW; Hyun SH; Lee SJ
    Anticancer Res; 2022 Dec; 42(12):5875-5884. PubMed ID: 36456151
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response.
    Cha SH; Kang KW; Han NY; Cho Y; Sung DJ; Park BJ; Kim MJ; Sim KC; Han YE; Sung HJ
    Abdom Radiol (NY); 2024 Jan; 49(1):341-353. PubMed ID: 37884749
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.
    Leung KH; Rowe SP; Sadaghiani MS; Leal JP; Mena E; Choyke PL; Du Y; Pomper MG
    J Nucl Med; 2024 Apr; 65(4):643-650. PubMed ID: 38423786
    [TBL] [Abstract][Full Text] [Related]  

  • 128. PET/CT in Hodgkin Lymphoma: An Update.
    Al-Ibraheem A; Mottaghy FM; Juweid ME
    Semin Nucl Med; 2023 May; 53(3):303-319. PubMed ID: 36369090
    [No Abstract]   [Full Text] [Related]  

  • 129. An Optimal Radiomics Nomogram Based on
    Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
    Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Interim FDG-PET/CT for Response Assessment of Lymphoma.
    Zeman MN; Akin EA; Merryman RW; Jacene HA
    Semin Nucl Med; 2023 May; 53(3):371-388. PubMed ID: 36376131
    [TBL] [Abstract][Full Text] [Related]  

  • 131. An Automated Method for Artifical Intelligence Assisted Diagnosis of Active Aortitis Using Radiomic Analysis of FDG PET-CT Images.
    Duff LM; Scarsbrook AF; Ravikumar N; Frood R; van Praagh GD; Mackie SL; Bailey MA; Tarkin JM; Mason JC; van der Geest KSM; Slart RHJA; Morgan AW; Tsoumpas C
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830712
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Prediction of Microsatellite Instability in Colorectal Cancer Using a Machine Learning Model Based on PET/CT Radiomics.
    Kim S; Lee JH; Park EJ; Lee HS; Baik SH; Jeon TJ; Lee KY; Ryu YH; Kang J
    Yonsei Med J; 2023 May; 64(5):320-326. PubMed ID: 37114635
    [TBL] [Abstract][Full Text] [Related]  

  • 133. A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT images: Initial analysis.
    Duff L; Scarsbrook AF; Mackie SL; Frood R; Bailey M; Morgan AW; Tsoumpas C
    J Nucl Cardiol; 2022 Dec; 29(6):3315-3331. PubMed ID: 35322380
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics.
    Jia T; Lv Q; Zhang B; Yu C; Sang S; Deng S
    BMC Med Imaging; 2023 Jul; 23(1):93. PubMed ID: 37460990
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
    Bodet-Milin C; Morvant C; Carlier T; Frecon G; Tournilhac O; Safar V; Kraeber-Bodere F; Le Gouill S; Macintyre E; Bailly C
    Sci Rep; 2023 Oct; 13(1):18177. PubMed ID: 37875524
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Machine Learning Model to Predict Diagnosis of Mild Cognitive Impairment by Using Radiomic and Amyloid Brain PET.
    Ciarmiello A; Giovannini E; Pastorino S; Ferrando O; Foppiano F; Mannironi A; Tartaglione A; Giovacchini G;
    Clin Nucl Med; 2023 Jan; 48(1):1-7. PubMed ID: 36240660
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Semi-automated
    Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
    Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
    Eertink JJ; Zwezerijnen GJC; Cysouw MCF; Wiegers SE; Pfaehler EAG; Lugtenburg PJ; van der Holt B; Hoekstra OS; de Vet HCW; Zijlstra JM; Boellaard R
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4642-4651. PubMed ID: 35925442
    [TBL] [Abstract][Full Text] [Related]  

  • 139. [18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake.
    Nieri A; Manco L; Bauckneht M; Urso L; Caracciolo M; Donegani MI; Borgia F; Vega K; Colella A; Ippolito C; Cittanti C; Morbelli S; Sambuceti G; Turra A; Panareo S; Bartolomei M
    Expert Rev Med Devices; 2023; 20(12):1183-1191. PubMed ID: 37942630
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Error mitigation enables PET radiomic cancer characterization on quantum computers.
    Moradi S; Spielvogel C; Krajnc D; Brandner C; Hillmich S; Wille R; Traub-Weidinger T; Li X; Hacker M; Drexler W; Papp L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3826-3837. PubMed ID: 37540237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.